Bristol-Myers Squibb

Related Content

Therapeutic: mavacamten for hypertrophic cardiomyopathy

Anteros enters the market powered by BioMotiv and Bristol-Myers Squibb

Bristol-Myers Squibb and Catalent close Italian manufacturing deal

Bristol-Myers Squibb invests in drug development accelerator BioMotiv

Catalent to acquire Bristol-Myers Squibb manufacturing plant in Italy

Biocartis and BMS to collaborate on MSI testing with immuno-oncology therapies

BMS' acquisition of Celgene could position the company amongst top five most profitable pharma giants

Bristol-Myers Squibb to merge with Celgene in multimillion deal

Eisai, BMS and H3 Biomedicine announce research collaboration

BMS and Vedanta announce a new clinical collaboration to evaluate OPDIVO (nivolumab) and VE800

GlobalData publishes analysis of top 25 global pharma companies

GlobalData names top 25 global pharma companies by market cap

Melanoma sales projected to rise to $5.5 bn in 2026

CTA for armed oncolytic virus treatment of solid tumours

Efficient handling of DNA samples with automatic capping solution